Barrett’s esophagus is a precursor to esophageal cancer, with early detection improving survival rates significantly. Definitions of Barrett’s esophagus vary, impacting esophageal cancer detection ...

Acid reflux can feel like your heart or chest is burning. If you've ever experienced acid reflux, you may have wondered if it ...

Hospital has launched advanced gastrointestinal endoscopy services in collaboration with Houston-based Baylor College of Medicine’s Center for Advanced Endoscopy.  The expansion brings Baylor Medicine ...

Sugar rationing in the first few years of life -- as happened for young kids in Britain during World War II -- was associated with a lower risk of metabolic dysfunction-associated steatotic liver ...

Debt Management: Castle Biosciences's debt-to-equity ratio is below the industry average. With a ratio of 0.08, the company relies less on debt financing, maintaining a healthier balance between debt ...

Q. I would encourage anyone on the fence about getting the Shingrix vaccine to seriously consider it. My elderly father had the older shingles vaccine but not Shingrix. Several years ago, he had ...

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsCamilla Zuckero - Vice President of Investor ...

Here are some more reasons: I’m 75 and I have a compromised immune system, including allergies that get quite severe sometimes. I can’t take the risk of getting COVID again, nor transmitting it to my ...

Q3 2025 Earnings Call Transcript October 30, 2025 Merit Medical Systems, Inc. beats earnings expectations. Reported EPS is $0 ...

As a result of the firm's financial results, Castle Bio raised its full-year 2025 revenue guidance to between $327 and $335 million from a range of $310 to $320 million.

The subsequent treatment involved intensive procedures, including five rounds of chemotherapy, external beam radiation, and ...

Combination therapy with cadonilimab, a first-in-class bispecific antibody targeting both PD-1 and CTLA-4, and chemotherapy offers encouraging antitumor activity and manageable safety as a first-line ...